ONFLEX™ LO 7120-45 ONFLEX™ HT 40A-3S2131 BERGAFLEX™ BFIG 45A-300 Applications HVAC Seals HVAC Seals HVAC Seals Interior - direct airflow Interior & exterior Interior - direct airflow HVAC feature Low VOC/FOG & odor Low VOC/FOG & odor Low odor Cold air Hot air Cold air VDA 270 ≤3.0 ≤3.0 ≤3.0 VOC/FOG VDA 278 (VOC) 97µg/g 100µg/g 196µg/g VDA 278 (FOG) 1131µg/g 1116µg/g 1707µg/g DIN 75201 (FOG) 0.3mg 1.7mg 1.1mg 73°F (23°C) 72 hrs 15% 12% 15% 158°F (70°C) 22 hrs 45% 28% 50% 212°F (100°C) 22 hrs 70% 45% 90% Density 1.15 g/ml 1.00 g/ml 1.17 g/ml Processing Injection Molding Injection Molding/ Extrusion Injection Molding Bonds to Polypropylene Polypropylene/ Polyethylene Polypropylene Hardness range 35–65 Shore A 40–70 Shore A 35–65 Shore A HOW GLS TPEs MAKE THE DIFFERENCE IN AUTOMOTIVE HVAC APPLICATIONS • Low VOC/FOG – externally tested to VDA 278 and shows significant reductions in volatile organic compounds and fogging when compared to current TPE technologies • Industry standards – helps to achieve VOC/ FOG performance standards for improved VIAQ • Reduced manufacturing steps – does not require pre-drying or post heating to reduce VOC in parts produced • Design optimization – color can be added at the machine • Easy to process – can be extruded, injection molded and extrusion blow molded • Recyclable – Our automotive TPEs are compatible with most municipal recycle streams • Global support – Avient automotive TPEs can be manufactured in locations that are convenient to your operations, including North America, Europe or China To learn more about GLS TPEs for automotive applications, contact Avient at +1.844.4AVIENT (+1.844.428.4368).

Richardson Executive Vice President, Chief Financial Officer PolyOne Corporation Page 15 Track Record of Accelerated Growth Total Revenue Adjusted EPS Adjusted EBITDA $2,061 $2,506 $2,709 $2,861 $3,771 2009 2010 2011 2012 2013 ($ in millions, except EPS ) $105 $179 $202 $255 $344 2009 2010 2011 2012 2013 $0.13 $0.68 $0.82 $1.00 $1.31 2009 2010 2011 2012 2013 PolyOne Corporation Page 16 $0.31 $0.44 $0.20 $0.30 $0.40 Q1 2013 Q1 2014 Adjusted EPS $42 $60 $20 $40 $60 Q1 2013 Q1 2014 Specialty Operating Income ($ millions) Q1 2014 Financial Highlights  Growth momentum accelerates driven by specialty platform  Specialty segments and Distribution achieve record results  All segments increase operating income compared to prior year  Revenue grew 25% versus Q1 2013 +43% +42% $57 $79 $30 $60 $90 Q1 2013 Q1 2014 Adjusted Operating Income ($ millions) +39% PolyOne Corporation Page 17 Commitment to Operational Excellence 81% 96% 2006 2013 16.2% 10.9% 2006 2013 On-Time Delivery Working Capital % of Sales 5.0% 31.0% 2006 2013 Percent of Associates Trained in LSS  Three consecutive years – CFO Magazine Best Working Capital Management Program in the chemical industry World’s Best Business Process Excellence Program in 2012*  95 certified Black Belts  211 certified Green Belts  422 Project Leaders World’s Best “Start-up Program” for Lean Six Sigma Deployment in 2009* *Both awards received from International Quality and Productivity Center PolyOne Corporation Page 18 Debt Maturities & Pension Funding – 3/31/14 Net Debt / EBITDA* = 1.9x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of March 31, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% *TTM 12/31/2013 ** includes US-qualified pension plans only 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of March 31, 2014 PolyOne Corporation Page 19 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return $0.16 $0.20 $0.24 $0.32 $0.10 $0.20 $0.30 $0.40 2011 2012 2013 2014 Annual Dividend  Expanding our sales, marketing, and technical capabilities  Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin  Synergy opportunities  Adjacent material solutions  Repurchased 1.4 million shares in Q1 2014  Repurchased 6.4 million shares since April 2013  13.6 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends  Investing in operational and LSS initiatives (including synergy capture)  Manufacturing alignment PolyOne Corporation Page 20 3.07 3.05 1.81 1.45 1.82 1.54 0.85 3.15 1.17 1.69 0.00 0.50 1.00 1.50 2.00 2.50 3.00 3.50 4.00 0.91 PolyOne Valuation Aspirations PEG Ratio Comparison Represents $38 of share price upside Avg = 1.96 PolyOne Corporation Page 21 Innovating for the Future Dr. Patterson President and Chief Executive Officer PolyOne Corporation Page 36 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 37 Innovation Drives Earnings Growth $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* *Percentage of Specialty Platform revenue from products introduced in last five years 14.3% 30.7% 2006 2013 Specialty Platform Gross Margin % 19.5% 43.0% 2006 2013 PolyOne Corporation Page 38 Formula for Success Innovation Market Beating Performance Excellence in Execution PolyOne Corporation Page 39 Track Record of Successful Integrations and Rapid Operating Income Growth $12 $44 2007 2013 $22 $30 2012 2013 $24 $49 2012 2013 GLS ColorMatrix Spartech OI in $ millions PolyOne Corporation Page 40 2015 and Beyond Innovation will drive the next stage in our remarkable transformation Deliver on 2015 goals Expand Specialty offerings and possibilities Identified as a truly global, specialty chemical company Market Potential Exceeds $40 Billion PolyOne Corporation Page 41 Driving Toward Premier Profitability EBIT Margins for top tier companies Victrex 42% Sigma Aldrich 18% FMC 25% IFF 18% Eastman 17% Hexcel 16% 16% Rockwood Holdings Celanese 14% 7% EBIT Margin – 2013 Albemarle 24% Ecolab 13% PolyOne Corporation Page 42 Bright Future & High Aspirations – The Next Seven Years • % OP Income from Specialty - 5% • Market Cap - $500 Million • Revenue - $2.6 Billion • Commodity Peers • Specialty ROS - 1.5% • % OP Income from Specialty - 62% • Market Cap - $3.5 Billion • Revenue - $3.7 Billion • Specialty ROS - 9.4% • % OP Income from Specialty - 80 to 90% • Market Cap - $12 to $18 Billion • Revenue - $8 to $10 Billion • Specialty Peers • Specialty ROS - ≥ 20% 2000 – 2006 2007 – 2013 2014 – 2020 PolyOne Corporation Page 43 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?

EPS (1) $0.14 $2.67 $3.04 2006 2018 2022PF TO P- TI E R S U S TA I N A B I L I T Y P E R F O R M A NC E A N D R E C O G N I T I O N Industry Sustainability Standards 90th percentile 84th ESG Ratings Performance 3 1 4 14 PEOPL E C U L T U R E I S E V E R Y T H I N G Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $17 million raised since 2010 Diversity & Inclusion 15 2 0 2 2 R E S U L T S Q4 EBITDA BRIDGE ( P R O F O R M A T O TA L C O M PA N Y ) 17 $ millions CAI: Price / Mix 42 Inflation (20) SEM: Price / Mix 14 Inflation (10) Net Price Benefit 26 Wage and Energy Inflation (13) Clariant Color Integration Synergies 4 Incentives, Other Employee Costs 21 FX (10) Q4 2022 $107 Adjusted EBITDA Q4 2021 $ 132 Demand (50) Russia Import Sales (3) • Demand contraction especially prevalent in EMEA and Asia • Pricing continues to cover inflation of raw materials, wages and energy P ROV E N T R AC K R E C O R D O F S T RO N G A N D I M P ROV I N G F R E E C A S H F LOW G E N E R AT I O N 18 • Periods of economic weakness have driven higher levels of cash generation due to working capital management • Anticipate continued strong free cash flow generation and conversion despite global uncertainty 78% 78% 80% 80% 81% 78% 84% 83% 80% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 50 100 150 200 250 300 350 400 F re e C a s h F lo w C o n v e rs io n F re e C a s h F lo w FCF $ AVNT FCF Conversion % S&P FCF Conversion % Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. 2020 is pro forma for Clariant Color and 2022 is pro forma for Avient Protective Materials $600 $592 2021 2022 $3.02 $3.04 2021 2022 FULL YEAR 2022 PERFORMANCE ( T O TA L C O M PA N Y P R O F O R M A ) 19 Sales Adjusted EBITDA $3,712 $3,653 2021 2022 - 2% Adjusted EPS - 1% + 1% (in millions) (in millions) (+ 4% excluding FX) (+ 5% excluding FX) (+ 9% excluding FX) FULL YEAR 2022 SEGMENT PERFORMANCE 20 CAI $2,402 $2,355 Sales ($ in millions) $409 $402 EBITDA SEM Pro Forma $1,308 $1,300 Sales $278 $272 EBITDA (+ 4% excluding FX) - 2% - 1% (+ 5% excluding FX) - 2% (+ 4% excluding FX) - 2% (+ 2% excluding FX) PRO FORMA FULL YEAR EPS BRIDGE 21 Pro Forma 2021 Adjusted EPS 3.02$ Foreign Currency (0.23) Russia Import Sales (0.07) Outdoor High Performance (0.13) Color, Additives and Inks 0.18 Specialty Engineered Materials 0.24 Corporate Costs / Other 0.03 Pro Forma 2022 Adjusted EPS 3.04$ FULL YEAR EBITDA BRIDGE ( P R O F O R M A T O TA L C O M PA N Y ) 22 $ millions CAI: Price / Mix 247 Inflation (176) SEM: Price / Mix 121 Inflation (77) Net Price Benefit 115 Wage and Energy Inflation (47) Clariant Color Integration Synergies 23 Incentives, Other Employee Costs 43 FX (34) Full Year 2022 $592 Adjusted EBITDA Full Year 2021 $ 600 Demand (99) Russia Import Sales (9) • Demand primarily impacted by China lockdowns, 4th quarter industrywide destocking and declining consumer sentiment • Pricing outpaced inflation of raw materials, wages and energy 2 0 2 3 G U I D A N C E $125 $530 Q1 FY $0.55 $2.40 Q1 FY 2023 GUIDANCE 24 Sales Adjusted EBITDA $845 $3,450 Q1 FY Adjusted EPS (in millions) (in millions) CA SH FLOW / BALANCE SHEET 25 • IT investment to further integrate acquired businesses and capture operational efficiencies • Restructuring actions to streamline operations and improve profitability, primarily in Europe ($ millions) 2023E Cash Flow from Operating Activities 350$ Less: Run-Rate CapEx (110) CapEx for IT System Upgrade (25) CapEx for Restructuring (15) Total CapEx (150) Free Cash Flow 200$ Adjusted EBITDA 530$ Net Debt / Adjusted EBITDA 2.9x K E Y G R O W T H D R I V E R S A N D T R A N S F O R M E D P O R T F O L I O GROW TH DR IVER S: PROV EN SUCC ESS 27 (1) Pro forma for the acquisition of Avient Protective Materials (APM) COMPOSITES $51 $84 $212 $668 2016 2018 2020 2022 Long Term Growth Rate 10% Organic CAGR 10% HEALTHCARE $108 $113 $231 $293 2016 2018 2020 2022 Long Term Growth Rate 8-10% Organic CAGR 11% ASIA/EMERGING REGIONS $265 $358 $726 $830 2016 2018 2020 2022 Long Term Growth Rate 5% Organic CAGR 12% $340 $455 $790 2016 2018 2020 2022 $1,175 SUSTAINABLE SOLUTIONS Long Term Growth Rate 8-12% Organic CAGR 11% (1) (1)(1) (Sales in $ millions) #1 Color Formulator Dyneema® - World’s Strongest Fiber™ #1 in Composites applications for outdoor high performance #1 in Performance Inks Customized solutions 140+ PhDs on staff Rapid development of innovative products Extensive patent (2,500+) portfolio 33% Vitality Index Better-positioned toward stable, high-growth end markets Consumer, packaging, healthcare and defense comprise nearly 60% of sales Agnostic to raw materials, helping all customers achieve their goals Broad portfolio of diversified sustainable solutions 90%+ of our innovation pipeline invested in sustainable solutions Long-term growth rate well above GDP with expectations of 8-12% L E V E R AG I N G O U R T R A N S F OR M E D PO RT F O L I O 28 Healthcare 8% Packaging 24% Consumer 20% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% 2022 PF $3.65B sales Defense 6% Leading Positions Sustainable SolutionsDiversified IndustriesSpecialty Formulator (1) 2022 Pro forma for the acquisition of Avient Protective Materials (2) 2020 Pro forma for the acquisition of Clariant Color (1)(2) (1) $340M $455M $790M 2016 2018 2020PF 2022PF $1,175M P E E R C O M PA R I S O N S AV I E N T I S A S SE T L I G H T Capex / Revenue 2023E (%) Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 estimated revenue of $3,450 and estimated run-rate CAPEX of $110M. 30 3 2 3 3 4 4 3 4 5 5 5 6 7 7 A vi e n t K W R P P G F U L A V Y R P M F M C H U N H X L C E E C L A S H S C L E M N F R E E C A S H F LOW C O N V E R S I O N Source: Peer data per Bloomberg as of February 13, 2023 Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 31 79 87 81 79 76 73 90 77 76 75 73 64 59 33 A vi e n t K W R P P G F U L A V Y R P M F M C C E A S H H X L E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.

EPS (1) $0.14 $2.67 $3.04 2006 2018 2022PF TO P- TI E R S U S TA I N A B I L I T Y P E R F O R M A NC E A N D R E C O G N I T I O N Industry Sustainability Standards 90th percentile 84th ESG Ratings Performance 3 1 4 10 PEOPL E C U L T U R E I S E V E R Y T H I N G Community Service 7x Safer than Industry Average World-Class Safety Leadership Development Over $17 million raised since 2010 Diversity & Inclusion 11 2 0 2 2 R E S U L T S Q4 EBITDA BRIDGE ( P R O F O R M A T O TA L C O M PA N Y ) 13 $ millions CAI: Price / Mix 42 Inflation (20) SEM: Price / Mix 14 Inflation (10) Net Price Benefit 26 Wage and Energy Inflation (13) Clariant Color Integration Synergies 4 Incentives, Other Employee Costs 21 FX (10) Q4 2022 $107 Adjusted EBITDA Q4 2021 $ 132 Demand (50) Russia Import Sales (3) • Demand contraction especially prevalent in EMEA and Asia • Pricing continues to cover inflation of raw materials, wages and energy P ROV E N T R AC K R E C O R D O F S T RO N G A N D I M P ROV I N G F R E E C A S H F LOW G E N E R AT I O N 14 • Periods of economic weakness have driven higher levels of cash generation due to working capital management • Anticipate continued strong free cash flow generation and conversion despite global uncertainty 78% 78% 80% 80% 81% 78% 84% 83% 80% 0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 2014 2015 2016 2017 2018 2019 2020 2021 2022 0 50 100 150 200 250 300 350 400 F re e C a s h F lo w C o n v e rs io n F re e C a s h F lo w FCF $ AVNT FCF Conversion % S&P FCF Conversion % Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. 2020 is pro forma for Clariant Color and 2022 is pro forma for Avient Protective Materials $600 $592 2021 2022 $3.02 $3.04 2021 2022 FULL YEAR 2022 PERFORMANCE ( T O TA L C O M PA N Y P R O F O R M A ) 15 Sales Adjusted EBITDA $3,712 $3,653 2021 2022 - 2% Adjusted EPS - 1% + 1% (in millions) (in millions) (+ 4% excluding FX) (+ 5% excluding FX) (+ 9% excluding FX) FULL YEAR 2022 SEGMENT PERFORMANCE 16 CAI $2,402 $2,355 Sales ($ in millions) $409 $402 EBITDA SEM Pro Forma $1,308 $1,300 Sales $278 $272 EBITDA (+ 4% excluding FX) - 2% - 1% (+ 5% excluding FX) - 2% (+ 4% excluding FX) - 2% (+ 2% excluding FX) PRO FORMA FULL YEAR EPS BRIDGE 17 Pro Forma 2021 Adjusted EPS 3.02$ Foreign Currency (0.23) Russia Import Sales (0.07) Outdoor High Performance (0.13) Color, Additives and Inks 0.18 Specialty Engineered Materials 0.24 Corporate Costs / Other 0.03 Pro Forma 2022 Adjusted EPS 3.04$ FULL YEAR EBITDA BRIDGE ( P R O F O R M A T O TA L C O M PA N Y ) 18 $ millions CAI: Price / Mix 247 Inflation (176) SEM: Price / Mix 121 Inflation (77) Net Price Benefit 115 Wage and Energy Inflation (47) Clariant Color Integration Synergies 23 Incentives, Other Employee Costs 43 FX (34) Full Year 2022 $592 Adjusted EBITDA Full Year 2021 $ 600 Demand (99) Russia Import Sales (9) • Demand primarily impacted by China lockdowns, 4th quarter industrywide destocking and declining consumer sentiment • Pricing outpaced inflation of raw materials, wages and energy 2 0 2 3 G U I D A N C E $125 $530 Q1 FY $0.55 $2.40 Q1 FY 2023 GUIDANCE 20 Sales Adjusted EBITDA $845 $3,450 Q1 FY Adjusted EPS (in millions) (in millions) CA SH FLOW / BALANCE SHEET 21 • IT investment to further integrate acquired businesses and capture operational efficiencies • Restructuring actions to streamline operations and improve profitability, primarily in Europe ($ millions) 2023E Cash Flow from Operating Activities 350$ Less: Run-Rate CapEx (110) CapEx for IT System Upgrade (25) CapEx for Restructuring (15) Total CapEx (150) Free Cash Flow 200$ Adjusted EBITDA 530$ Net Debt / Adjusted EBITDA 2.9x K E Y G R O W T H D R I V E R S A N D T R A N S F O R M E D P O R T F O L I O GROW TH DR IVER S: PROV EN SUCC ESS 23 (1) Pro forma for the acquisition of Avient Protective Materials (APM) COMPOSITES $51 $84 $212 $668 2016 2018 2020 2022 Long Term Growth Rate 10% Organic CAGR 10% HEALTHCARE $108 $113 $231 $293 2016 2018 2020 2022 Long Term Growth Rate 8-10% Organic CAGR 11% ASIA/EMERGING REGIONS $265 $358 $726 $830 2016 2018 2020 2022 Long Term Growth Rate 5% Organic CAGR 12% $340 $455 $790 2016 2018 2020 2022 $1,175 SUSTAINABLE SOLUTIONS Long Term Growth Rate 8-12% Organic CAGR 11% (1) (1)(1) (Sales in $ millions) #1 Color Formulator Dyneema® - World’s Strongest Fiber™ #1 in Composites applications for outdoor high performance #1 in Performance Inks Customized solutions 140+ PhDs on staff Rapid development of innovative products Extensive patent (2,500+) portfolio 33% Vitality Index Better-positioned toward stable, high-growth end markets Consumer, packaging, healthcare and defense comprise nearly 60% of sales Agnostic to raw materials, helping all customers achieve their goals Broad portfolio of diversified sustainable solutions 90%+ of our innovation pipeline invested in sustainable solutions Long-term growth rate well above GDP with expectations of 8-12% L E V E R AG I N G O U R T R A N S F OR M E D PO RT F O L I O 24 Healthcare 8% Packaging 24% Consumer 20% Building & Construction 10% Industrial 15% Transportation 9% Energy 4% Telecom. 4% 2022 PF $3.65B sales Defense 6% Leading Positions Sustainable SolutionsDiversified IndustriesSpecialty Formulator (1) 2022 Pro forma for the acquisition of Avient Protective Materials (2) 2020 Pro forma for the acquisition of Clariant Color (1)(2) (1) $340M $455M $790M 2016 2018 2020PF 2022PF $1,175M P E E R C O M PA R I S O N S AV I E N T I S A S SE T L I G H T Capex / Revenue 2023E (%) Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 estimated revenue of $3,450 and estimated run-rate CAPEX of $110M. 27 3 2 3 3 4 4 3 4 5 5 5 6 7 7 A vi e n t K W R P P G F U L A V Y R P M F M C H U N H X L C E E C L A S H S C L E M N F R E E C A S H F LOW C O N V E R S I O N Source: Peer data per Bloomberg as of February 13, 2023 Note: Free cash flow conversion calculated as (Adjusted EBITDA – Capex) / Adjusted EBITDA. Avient Specialty Formulators Other Specialty / Chemical Companies 2023E(%) 28 79 87 81 79 76 73 90 77 76 75 73 64 59 33 A vi e n t K W R P P G F U L A V Y R P M F M C C E A S H H X L E C L H U N E M N S C L M U LT I P L E E X PA N S I O N Avient Specialty Formulators Other Specialty / Chemical Companies Source: Peer data per Bloomberg as of February 13, 2023 Note: Avient reflects 2023 adjusted EBITDA guidance of $530M and closing share price of $38.89.

This agreement would be equal to approximately 90% of our annual European electricity needs. This agreement would be equal to approximately 90% of our annual European electricity needs. Current: • Approximately 90% of Avient’s products met these criteria in 2019

Figure 1: Tensile test data as a function of the fibre orientation 0° (orange), 45° (green), 90° (blue) https://www.hexagonmi.com Figure 4: Failure location in the flexural test for the isotropic modelling Figure 6: Failure location in the tensile test for the isotropic modelling approach (left), Digimat anisotropic modelling approach (middle) and reality (right) Figure 3: Flexural test results with the isotropic modelling approach (orange) and Digimat anisotropic modelling approach (green) Figure 5: Tensile test results with the isotropic modelling approach (orange) and Digimat anisotropic modelling approach (green) Figure 5 shows the tensile test results with, again, a convincing advantage for the Digimat anisotropic modelling approach against the isotropic modelling approach.

VERSAFLEX™ HC MEDICAL TUBING SERIES • Improve extrusion rates, achieve high service temperature performance or increase clarity in medical tubing • Meet biopharmaceutical needs for weldability and minimize extractables during processing VERSALLOY™ HC SERIES • Obtain better flow in long, thin paths and lower shrink rates versus typical TPVs with our alloys, made with Santoprene™ TPV • Color easily and obtain a smooth tactile feel VERSAFLEX™ HC GASKETS & STOPPERS SERIES • Achieve no coring, good puncture and resealability in static stoppers • Meet low COF and low stiction requirements in dynamic seals VERSAFLEX™ CL E SERIES • Increase clarity and flexibility in bags, bottles and films • Mitigate risk with plasticizer-free formulations for film extrusion • Deliver excellent odor & O 2 barrier performance for film extrusion INDUSTRY BULLETIN TPE HEALTHCARE PRODUCT SELECTOR GUIDE Versaflex™ HC MT Series Versaflex™ HC MT222 Clear 66A 0.88 14 - 334 2.30 629 4.34 898 6.19 430 220 36 ✔ ✔ High clarity, without plasticizers Versaflex™ HC MT224 Clear 75A 0.89 19 - 468 3.23 773 5.33 1360 9.40 530 321 56 ✔ ✔ Versaflex™ HC MT226 Clear 84A 0.88 20 - 606 4.17 885 6.10 1600 11.00 600 433 76 ✔ ✔ Versaflex™ HC MT317 Clear 68A 0.89 17 69 450 3.10 660 4.55 870 6.00 470 221 39 ✔ ✔ Very high service temperature Versaflex™ HC BT218 Natural 67A 0.89 19 69 381 2.60 683 4.70 1186 8.20 608 - - ✔ ✔ Weldable, kink resistant Versaflex™ HC Gaskets & Stoppers Series Versaflex™ HC 2110-35N Natural 34A 0.90 19 47 145 1.00 261 1.80 400 2.76 620 97 17 ✔ ✔ Good resealing Versaflex™ HC 2110-43N Natural 43A 0.98 12 46 134 0.92 368 2.54 723 4.98 710 - - ✔ ✔ Good compression set Versaflex™ HC 2110-57B Black 59A 1.01 20 37 369 2.54 558 3.85 537 3.70 350 147 26 ✔ ✔ Low stiction Versaflex™ CL E Series Versaflex™ CL E85 Clear 84A 0.90 20 72 752 5.18 1160 8.00 1550 10.70 450 433 76 ✔ ✔ High clarity, without plasticizers; E95 also offers excellent odor & O 2 barrier Versaflex™ CL E90 Clear 90A 0.90 27 73 1000 6.89 1230 8.50 1830 12.60 57 - - ✔ ✔ Versaflex™ CL E95 Clear 95A 0.90 38 71 1680 11.60 1730 11.90 2500 17.20 580 720 126 ✔ ✔ Versaflex™ HC 3810 Series Versaflex™ HC 3810-20N Natural 20A 0.88 16 54 123 0.80 185 1.30 342 2.40 650 - - ✔ - Formulated without animal derivatives, excellent colorability, translucent Versaflex™ HC 3810-30N Natural 30A 0.89 18 58 170 1.20 245 1.70 459 3.20 680 - - ✔ - Versaflex™ HC 3810-40N Natural 40A 0.88 19 59 191 1.30 275 1.90 506 3.50 670 - - ✔ - Versaflex™ HC 3810-50N Natural 50A 0.89 21 61 264 1.80 366 2.50 699 4.80 690 - - ✔ - Versaflex™ HC 3810-60N Natural 60A 0.88 24 65 459 3.20 594 4.10 790 5.40 510 - - ✔ - Versaflex™ HC 3810-70N Natural 70A 0.88 28 67 535 3.70 684 4.70 1000 6.90 570 - - ✔ - Versaflex™ HC 3810-80N Natural 80A 0.88 30 67 689 4.80 869 6.00 1390 9.60 620 - - ✔ - Versaflex™ HC 3810-90N Natural 90A 0.88 27 89 1087 7.50 1350 9.30 1890 13.00 570 - - ✔ - Versalloy™ HC 9210 Series Versalloy™ HC 9210-45N Natural 45A 0.89 19 39 160 1.10 320 2.20 484 3.33 480 100 18 - ✔ Smooth surface aesthetics Versalloy™ HC 9210-55N Natural 53A 0.89 20 44 208 1.44 335 2.31 580 4.00 610 120 21 - ✔ Versalloy™ HC 9210-70N Natural 70A 0.89 23 53 356 2.45 510 3.52 780 5.38 590 180 32 - ✔ Versalloy™ HC 9220 Series Versalloy™ HC 9220-70 Natural 70A 0.95 17 51 453 3.12 - - 643 4.43 265 208 36 ✔ ✔ ExtrudableVersalloy™ HC 9220-80 Natural 80A 0.94 18 59 553 3.67 777 5.36 945 6.52 415 208 36 ✔ ✔ Versalloy™ HC 9220-90 Natural 90A 0.94 25 55 1030 8.13 1350 9.33 1945 13.45 620 400 70 ✔ ✔ Standard Healthcare Grades Versaflex™ G2705N Natural 60A 0.88 - - - - 528 3.64 670 4.62 470 - - ✔ ✔ Natural, high strength Versaflex™ CL 2242 Clear 43A 0.89 23 - 152 1.05 294 2.02 731 5.00 780 124 22 ✔ ✔ High clarity, boilable Versaflex™ CL 2250 Clear 50A 0.89 20 - 220 1.52 337 2.32 827 5.70 770 140 25 ✔ ✔ Versaflex™ OM Series Versaflex™ OM 1040X Natural 42A 0.92 22 - 180 1.24 301 2.08 504 3.47 580 100 18 ✔ ✔ ABS/PC overmoldVersaflex™ OM 3060 Clear 59A 0.90 33 - 420 2.90 360 2.48 500 3.45 480 180 32 ✔ ✔ Color Hardness Specific Gravity Compression Set @ 23°C Compression Set @ 100°C 100% Modulus 300% Modulus Tensile Strength Elongation Tear Strength ISO 10993 USP VI Special Characteristics ASTM Shore A ASTM/ISO ASTM % ASTM % ASTM psi Mpa ASTM psi Mpa ASTM psi ISO Mpa ASTM % ASTM pll ISO kN/m GENERAL PROPERTIES TENSILE PROPERTIES OTHER For further information on specific grades, review technical data sheets.

Působnost valné hromady Společnosti přijímat Rozhodnutí dle článku III. notářského zápisu byla notáři prokázána, a to zejména předloženým zakladatelským právním jednáním Společnosti v úplném znění a ustanovením § 190 odst. 2 zákona č. 90/2012 Sb., o obchodních společnostech a družstvech (dále též „zákon o obchodních korporacích“ nebo „ZOK“). ----------------------------- 3.

 2002, PolyOne Corporation TCLF_PRODUCTS_12/04/01

Box 5882 Riyadh, Kingdom Saudi Arabia Activity: Administration, Site management, Manufacture, Laboratory, Procurement, Maintenance, Infrastructure, Warehouse and Transport Activity: Administration, Site management, Manufacture, Laboratory, Procurement, Maintenance, Infrastructure, Warehouse and Transport Facility: Avient Colorants Singapore Pte Ltd 1 International Business Park #08-01-04 The Synergy Singapore, SINGAPORE 609917 Singapore Facility: Avient Colorants Singapore Pte Ltd 8 Third Chin Bee Road Jurong Industrial Estate Singapore, SINGAPORE 618684 Singapore Activity: Administration, Site management, Manufacture, Laboratory, Procurement, Maintenance, Infrastructure, Warehouse and Transport Activity: Administration, Site management, Manufacture, Laboratory, Procurement, Maintenance, Infrastructure, Warehouse and Transport Facility: Avient Pakistan (Private) Ltd. 1–A1, Sector 20 Korangi Industrial Area Karachi, Sindh 74900 Pakistan Facility: Avient Pakistan (Private) Ltd.